Topical Imiquimod Plus Nab-paclitaxel for Breast Cancer Cutaneous Metastases

This phase 2, single-arm clinical trial examines the safety and objective response rate of topical imiquimod in combination with systemic chemotherapy for treatment of breast cancer cutaneous metastases.

http://ift.tt/2jcKgrX